HSIL - Hemant Surgical Industries Limited Share Price

Healthcare Equipment & Supplies

₹851.35-19.60(-2.25%)

Market Closed as of Sep 29, 2025, 15:30 IST

Select time range

Valuation
Market Cap	892.72 Cr
Price/Earnings (Trailing)	111.05
EV/EBITDA	69.71
Price/Free Cashflow	100.07
MarketCap/EBT	85.3
Enterprise Value	883.18 Cr

Fundamentals
Earnings (TTM)	8.04 Cr

Profitability
Return on Assets	5.42%
Free Cashflow Yield	1%

Price to Sales Ratio

Revenue (Last 12 mths)

Latest reported: 11 Cr

Net Income (Last 12 mths)

Latest reported: 8 Cr

Growth & Returns
Price Change 1W	3.3%
Price Change 1M	-4.3%
Price Change 6M	730%
Price Change 1Y	-10.7%
3Y Cumulative Return	36.8%
5Y Cumulative Return	60.7%
7Y Cumulative Return	43%
10Y Cumulative Return	27.7%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-30.28 Cr
Cash Flow from Operations (TTM)	8.92 Cr
Cash Flow from Financing (TTM)	17.64 Cr
Cash & Equivalents	9.55 Cr
Free Cash Flow (TTM)	8.92 Cr
Free Cash Flow/Share (TTM)	8.54

Balance Sheet
Total Assets	148.31 Cr
Current Assets	88.8 Cr
Current Liabilities	61.26 Cr
Inventory	43.14 Cr

Capital Structure & Leverage
Debt Ratio	0.00
Interest Coverage	3.75
Interest/Cashflow Ops	5.05

Dividend & Shareholder Returns
Shares Dilution (1Y)	0.00%

Pros

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Past Returns: Outperforming stock! In past three years, the stock has provided 36.8% return compared to 11.2% by NIFTY 50.

Cons

Size: It is a small market cap company and can be volatile.

Dividend: Stock hasn't been paying any dividend.

Insider Trading: Significant insider selling noticed recently.

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Investor Care
Shares Dilution (1Y)	0.00%
Earnings/Share (TTM)	7.7

Financial Health
Current Ratio	1.45

Technical Indicators
RSI (14d)	50.14
RSI (5d)	0.00
RSI (21d)	45.82
MACD Signal	Sell
Stochastic Oscillator Signal	Buy
Grufity Signal	Sell
RSI Signal	Hold
RSI5 Signal	Buy
RSI21 Signal	Hold
SMA 5 Signal	Sell
SMA 10 Signal	Sell
SMA 20 Signal	Sell
SMA 50 Signal	Sell
SMA 100 Signal	Sell

Summary of Latest Earnings Report from Hemant Surgical Industries

Summary of Hemant Surgical Industries's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

Earnings Outlook

Last updated:

Q&A Session

Last updated:

Share Holdings

Understand Hemant Surgical Industries ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

Shareholder Name	Holding %
HANSKUMAR SHAMJI SHAH	27.05%
KAUSHIK HANSKUMAR SHAH	16.13%
HEMANT PRAFUL SHAH	13.3%
Singularity Large Value Fund I	3.83%
Wealthwave Capital Fund	3.07%
SURESH ZUNZUNWALA	2.58%
MONA LAROIA	2.52%
Swati Pokharna	2.3%
Renudevi Hisaria	2.3%
Singularity Large Value Fund III	1.91%
Singularity Equity Fund I	1.91%
PM Investment	1.53%
HARSHA VENKATESH	0.84%
SACHIN KUMAR BHARTIYA	0.8%
Upahar Homfin Private Limited	0.77%
Free India Assurance Services Limited	0.77%
Naresh Saraaf	0.77%
NAMAN HEMANT SHAH	0.73%
LEENA HANSKUMAR SHAH	0.67%
NEHA HANSKUMAR SHAH	0.6%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Is Hemant Surgical Industries Better than it's peers?

Detailed comparison of Hemant Surgical Industries against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
		-	-	-	-	-	-	-	-

Sector Comparison: HSIL vs Healthcare Equipment & Supplies

Comprehensive comparison against sector averages

Comparative Metrics

HSIL metrics compared to Healthcare

Category	HSIL	Healthcare
PE	42.25	38.98
PS		5.26
Growth	NA %	8.7 %

Performance Comparison

HSIL vs Healthcare (2021 - 2025)

Key Insights

1. HSIL is NOT among the Top 10 largest companies in Healthcare.
2. The company holds a market share of NA% in Healthcare.
3. null

Income Statement for Hemant Surgical Industries

Consolidated figures (in Rs. Crores) / View Standalone Data

AnnualQuarterly

Revenue From Operations	-
Other income	-
Cost of Materials	-
Employee Expense	-
Finance costs	-
Other expenses	-
Total Expenses	-
Total profit before tax	-
Current tax	-
Deferred tax	-
Tax expense	-
Net profit (loss) for the period	-
Earnings Per Share, Basic	-
Earnings Per Share, Diluted	-

Standalone figures (in Rs. Crores) / View Consolidated Data

AnnualQuarterly

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Revenue From Operations	1%	107	106	1,853	1,859	2,710	2,285
Other income	24.2%	5.11	4.31	28	20	30	9.71
Total Revenue	-	-	110	-	-	-	-
Cost of Materials	17.7%	94	80	728	726	620	417
Purchases of stock-in-trade	-	0	0	0.01	46	511	547
Employee Expense	26.2%	9.33	7.6	223	227	360	309
Finance costs	4100%	2.2	0.97	72	73	87	56
Other expenses	33.3%	13	10	581	671	901	814
Total Expenses	4.2%	101	97	1,766	1,804	2,632	2,182
Total profit before tax	-16.7%	11	13	115	75	108	106
Current tax	-25.7%	2.65	3.22	1.34	0	8.58	28
Deferred tax	0.8%	-0.23	-0.24	25	27	29	3.11
Tax expense	-28.3%	2.42	2.98	27	27	37	31
Net profit (loss) for the period	-19%	8.13	9.8	-	-	-	-
Reserve excluding revaluation reserves	-	0	-	954	965	0	0
Earnings Per Share, Basic	-23.3%	7.79	9.85	12.71	6.69	9.74	10.34
Earnings Per Share, Diluted	-23.3%	7.79	9.85	12.71	6.69	9.74	10.34

Description	(%) Q/Q	Dec-2021	Sep-2021	Jun-2021	Mar-2021	Dec-2020	Sep-2020
Revenue From Operations	17.1%	639	546	416	633	541	426
Other income	-74.3%	5.89	20	3.76	5.01	6.11	13
Cost of Materials	12.5%	271	241	192	239	216	176
Purchases of stock-in-trade	-	0	0	0	0	0	0
Employee Expense	10%	67	61	63	67	62	54
Finance costs	-6.2%	16	17	16	15	19	19
Other expenses	37.8%	216	157	167	178	153	142
Total Expenses	15.2%	599	520	403	582	497	406
Total profit before tax	-4.3%	45	47	17	57	51	33
Current tax	-49.5%	7.57	14	5.8	13	3.46	-14.71
Deferred tax	509.8%	9.11	2.33	0.13	11	12	12
Tax expense	6.7%	17	16	5.93	24	15	-3.12
Reserve excluding revaluation reserves	-	-	-	-	954	-	-
Earnings Per Share, Basic	-8.1%	4.4	4.7	1.74	4.77	5.08	5.04
Earnings Per Share, Diluted	-8.1%	4.4	4.7	1.74	4.77	5.08	5.04

Balance Sheet for Hemant Surgical Industries

Consolidated figures (in Rs. Crores) / View Standalone Data

Cash and cash equivalents	-
Inventories	-
Reserves and surplus	-
Total current assets	-
Non-current investments	-
Total non-current assets	-
Total assets	-
Total non-current liabilities	-
Total current liabilities	-
Total equity and liabilities	-

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Mar-2025	Mar-2024	Sep-2023	Sep-2021	Mar-2021	Sep-2020
Cash and cash equivalents	-29.5%	9.46	13	21	5.54	3.74	5.11
Fixed assets	-	-	18	17	-	-	-
Inventories	105%	42	21	23	525	436	414
Reserves and surplus	20.9%	53	44	38	-	-	-
Total current assets	27.9%	88	69	68	879	886	921
Non-current investments	-88.5%	1.45	4.93	0.01	11	11	12
Total non-current assets	126.9%	60	27	22	2,110	1,970	1,934
Total assets	53.1%	148	97	90	2,989	2,856	2,855
Total non-current liabilities	669.2%	24	3.99	6.48	1,078	960	994
Total current liabilities	62.2%	61	38	35	661	663	607
Total equity and liabilities	53.1%	148	97	90	2,989	2,856	2,855

Cash Flow for Hemant Surgical Industries

Consolidated figures (in Rs. Crores) / View Standalone Data

Profit Before Extraord. Items And Tax	-
Finance costs	-
Depreciation	-
Total adjustments to profit/loss	-
Change in inventories	-
Change in trade receivables	-
Change in trade payables	-
Adjustments for Provisions	-
Total adj. for working capital	-
Net Cashflows From Operations	-
Interest received	-
Income taxes paid (refund)	-
Other inflows/outflows of cash	-
Net Cashflows From Operating Activities	-
Proceeds from sales of intangible assets	-
Interest received	-
Other inflows/outflows of cash	-
Net Cashflows From Investing Activities	-
Proceeds from borrowings	-
Interest paid	-
Net Cashflows From Financing Activities	-
Net change in cash and cash eq.	-

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Profit Before Extraord. Items And Tax	-16.7%	11	13	-	-	-	-
Finance costs	2016.7%	2.15	0.94	-	-	-	-
Depreciation	1300%	1.42	1.03	-	-	-	-
Total adjustments to profit/loss	289.6%	4.74	1.96	-	-	-	-
Change in inventories	-209.7%	-21.42	-6.24	-	-	-	-
Change in trade receivables	107.8%	1.43	-4.54	-	-	-	-
Change in trade payables	2341.4%	14	0.42	-	-	-	-
Adjustments for Provisions	51.6%	0.38	-0.28	-	-	-	-
Total adj. for working capital	75.3%	-3.68	-17.96	-	-	-	-
Net Cashflows From Operations	360.7%	12	-3.22	-	-	-	-
Interest received	25%	-0.59	-1.12	-	-	-	-
Income taxes paid (refund)	-58.1%	1.93	3.22	-	-	-	-
Other inflows/outflows of cash	-	-0.18	0	-	-	-	-
Net Cashflows From Operating Activities	192.5%	8.92	-7.56	-	-	-	-
Purchase of tangible assets	-	-	5.52	-	-	-	-
Interest received	-441.7%	0.59	1.12	-	-	-	-
Other inflows/outflows of cash	162.1%	4.46	-4.57	-	-	-	-
Net Cashflows From Investing Activities	-213.7%	-30.28	-8.97	-	-	-	-
Proceeds from issuing shares	-104.8%	0	22	-	-	-	-
Proceeds from borrowings	3753.8%	20	0.48	-	-	-	-
Interest paid	2016.7%	2.15	0.94	-	-	-	-
Net Cashflows From Financing Activities	-15%	18	21	-	-	-	-
Net change in cash and cash eq.	-227%	-3.71	4.71	-	-	-	-

HSIL - Hemant Surgical Industries Limited Share Price

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution